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Abstract
Background: In many European countries, medical education on alcohol remains inadequate in
terms of both quantity and quality. The expansion of GP training and care protocols would improve
the management and outcome of alcoholic patients. Our purpose was to assess the impact of a
multifaceted intervention by trained GPs in the management of alcohol-dependent patients.
Results and discussion: Trained GPs proved better i) in the attempt at abstinence, with 67%
patients becoming sober vs. 47% in a comparison sample and ii) in repeat attempt at abstinence in
the event of relapse, with an average 2.99 vs. 1.31 attempts per patient. There were no differences
in terms of i) relapses, which involved about three in four patients, and ii) prolonged abstinence,
which averaged two months. Overall, patients managed by trained GPs remained abstinent 103
days during the 18-month follow-up period vs 68 days for the comparison sample (p = 0.016).
Methods: This 18-month follow-up study had a quasi-experimental design with 24 volunteer
trained GPs and a comparison sample of a representative sample of 24 GPs. All GPs included their
own already existing DSM-IV alcohol-dependent patients. Patients with depression or anxiety
comorbidities were included. Participants were 126 patients in the trained sample and 122 in the
comparison sample. The two patient samples were evenly-balanced, averaging 47 years old and 80%
males. In the trained sample, consultations were scheduled and management (medication, biological
workup) was protocolized, whereas the comparison sample representing standard practice had no
obligations.
Conclusion:  Medical education can sharply improve the management of alcohol-dependent
patients and short-term outcome. Trained GPs lead more patients to attempt abstinence and more
often than in standard practice. However, a strict medical approach remains limited in the
maintenance of medium-term abstinence (over two months), providing a strong argument for
multidisciplinary management of alcohol-dependent patients.
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Background
General practice represents the primary care system in
France. Three quarters of the French population consult a
GP at least once every year, and 92% stay nested within
their attending physician [1].
Twenty percent of GP's patients present with alcohol use
disorders (5% dependence) [2]. Although these alcohol-
related problems are relatively common, GPs are still find-
ing it difficult to identify and manage these patients [3].
GPs commitment or ability may be hampered by individ-
ual factors such as knowledge levels, skills, attitudes,
beliefs and expectations. These factors can be improved by
education and training [4,5]. However, initial medical
training on alcohol misuse varies between French univer-
sities, and represents only 4–10 hours of instruction [6].
The centre of France ranks among the leading French
regions in terms of incidence of alcohol use disorders [7].
Local training initiatives have been set up for volunteer
GPs covering alcohol misuse (especially alcohol depend-
ence) and healthcare protocols. In 2001, these practition-
ers were integrated into an experimental healthcare
network approved by the French Ministry of Health [8].
They were given university training with field-work
instruction (available in every French university) followed
by ongoing training comprised of role-playing and simu-
lation exercises. Figure 1 gives a brief illustration of the
healthcare protocol (based on the recommendations of
the French Society of Alcohology [9,10]) corresponding to
over 80% of the patients included in the network. This
protocol mainly gives a framework for follow-up. It
defines a minimal frequency of consultation according to
the patient's state of change. The systematic use of follow-
up tools such as self-questionnaires and biological work-
up is reported to improve patient motivation. Medical
files are managed via a networked database for patient fol-
low-up that gives the stage of the protocol and also man-
ages payment of the practitioners. Remunerations are
based on an all-inclusive fee taking into account this time-
intensive management strategy. The functioning of the
network is exhaustively described in the Official Journal
of the French Republic, which can be found at [11].
The aim of this study was to assess the impact of this prac-
titioner training plus healthcare protocol strategy on out-
come in alcohol-dependent patients versus a comparative
sample during an 18-month follow-up period. Each GP
included any of his or her existing eligible patients accord-
ing to the quasi-experimental design of the study.
Results and discussion
Practitioners and patients
All volunteer practitioners in the trained sample were
males and their average experience as a GP was 14.3 years
[SD 5.1]. In the random comparison sample, the GPs
(70% were males) had an average 17.6 years [SD 6.3] of
experience and had received an average 10 hours of tutor-
ing on alcohol misuse during their medical studies.
126 patients were included in the trained GPs sample, i.e.
5.3 [SD 4.9] patients per GP, and 122 patients were
included in comparison sample, i.e. 5.1 [SD 4.4] patients
per GP.
The two patient samples were very similar in terms of
socio-demographic and clinical data (Table 1). The male-
to-female gender ratio was 5/1, with an average age of 47
years old. These characteristics are usual in alcohol misuse
studies incorporating clinical samples [12]. There were
more physical dependents (92 vs. 84%) and significantly
(Fisher's exact p = 0.04) longer-standing alcohol problems
in the trained sample. There was a very high incidence of
psychiatric comorbidities in both the trained and the
comparison sample (anxiety 79% and 84%, depression
55% and 57%, respectively: Fisher's exact p = 0.24 and
Fisher's exact p = 0.77) which is in agreement with the
highest prevalence reported in the literature [13-15].
The results are based on a total of 1,867 consultations in
the trained sample, i.e. 15.5 [SD 13.8] per patient, and
883 consultations in the comparison sample, i.e. 7.2 [SD
4.5], over an 18-month period. The incidence of a man-
agement strategy was higher in the trained sample, fitting
with the protocol.
Lost to follow-up and deceased
Patients lost to follow-up were those patients included
and then never seen during the 18-month follow-up
period. Ten patients were lost to follow-up in the trained
sample (8%) and 3 (2%) in the comparison sample
(Fisher's exact p = 0.09). Loss to follow-up at one year var-
ies between 15% and 30% in general practice studies [16].
Our very low rate of loss to follow-up at 18 months is
probably due to the quasi-experimental design of the
study and confirms the patients' loyalty to their attending
practitioner. In both samples patients are nested within
their practitioner like 92% of the French population.
Three patients (2%) in the trained sample and 9 patients
(7%) in the comparison sample died during the study, all
due to alcohol-related complications (Fisher's exact p =
0.12). Mortality was consistent with previously reported
figures for a cohort follow-up study of alcohol misuse
[17].
Attempts at abstinence and relapses
Attempts at abstinence were more frequent in the trained
sample: 67% of patients stop drinking compared to 46%
of patients in the comparison sample (Fisher's exact p <Substance Abuse Treatment, Prevention, and Policy 2006, 1:18 http://www.substanceabusepolicy.com/content/1/1/18
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Summary of follow-up by GP alone (protocol D1) in the trained sample Figure 1
Summary of follow-up by GP alone (protocol D1) in the trained sample. A minimum consultation frequency is scheduled 
according to patients' state of change. Prescriptions (medications, biological work-up) are protocolized. Contra-indications to 
ambulatory withdrawal are based on the recommendations of the French Society of Alcohology [9, 10].
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0.0001). At the last recorded observation, 23% of patients
in the trained sample were abstinent compared to 17% in
the comparison sample (Fisher's exact p = 0.36). How-
ever, relapses were more frequent in the trained sample
(87 vs. 67%, Fisher's exact p = 0.003). Longest period of
abstinence was significantly different between the two
samples but appeared to be relatively short and very close
in both samples: 68.1 days [SD 9.9] in the trained sample
vs 61.7 days [SD 9.7] in the comparison sample (Mann-
Whitney chi-square = 6.32, df = 1, p = 0.01). There were
no differences in any socio-demographic characteristics or
alcohol consumption profiles between study samples,
subsets of patients attempting abstinence or the subset of
relapsing patients (Table 1).
Repeated attempts at abstinence and relapses
Average frequency of attempt at abstinence and number
of relapses per patient were twofold higher in trained sam-
ple patients than comparison sample patients (2.99 vs.
1.35 for attempts and 3.23 vs. 1.21 for relapses). In addi-
tion to higher initiation rates for attempt at abstinence,
the main between-sample difference concerned the ability
of the trained sample to repeat abstinence attempts, lead-
ing to a much longer cumulative duration of abstinence:
102.9 days [SD 13.5] in the trained sample compared to
68.4 days [SD 10.6] in the comparison sample (Mann-
Whitney chi-square = 9.63, df = 1, p = 0.002). Trained
sample patients remained abstinent for an average 36% of
the follow-up period, compared to only 16% for the com-
parison sample (Fishers' exact p = 0.016).
These different between sample-patterns were represented
graphically, showing survival analysis and repeat attempt
at abstinence patterns in the trained sample (Figure 2) and
the high relapse rate during the first two or three months
after drinking cessation in both samples (Figure 3). Differ-
ences are significant in a Cox model for multiple events
(for attempts at abstinence: Wald chi-square = 14, df = 1,
Cox p < 0.0001; for relapses: Wald chi-square = 37.2, df =
1, Cox p < 0.0001) and were confirmed with the log-rank
test in both cases when the model included each patient
only once, at first attempt at abstinence or first relapse.
A multivariate Cox model of multiple events was run to
identify whether between-sample differences persisted
following adjustment for other covariates:
- attempt at abstinence remained related to a sample effect
(Wald chi-square = 11.65, df = 1, Cox p < 0.001), but was
also related to frequency of consultations (Wald chi-
square = 23.78, df = 1, Cox p < 0.0001) and the prescrip-
tion of benzodiazepines (Wald chi-square = 4.49, df = 1,
Cox p = 0.03), which were frequently prescribed in both
sample and are considered standard practice for any GP in
the early stages of withdrawal for these mainly physically-
dependent patients [18].
- for relapses, the adjustments cancelled out the between-
sample difference (Wald chi-square = 2.04, df = 1, Cox p
= 0.15). The occurrence of relapse appeared to only be
related to frequency of consultations (Wald chi-square =
15.80, df = 1, Cox p < 0.0001) and onset of anxiety disor-
der (Wald chi-square = 5.52, df = 1, Cox p = 0.02). This
link between alcohol consumption and anxiety has been
described previously [19,20].
Table 1: Sociodemographic and clinical data. All percentages were tested using Fisher's exact and continuous variables were tested 
using Mann-Whitney tests
Study population Patients attempting 
abstinence
Relapsing patients
Trained sample Comparison 
sample
Trained sample Comparison 
sample
Trained sample Comparison 
sample
n = 126 n = 122 n = 85 n = 57 n = 74 n = 38
Gender (% of men) 80% 83% 82.4% 86% 86.5% 81.3%
Age (mean [SD]) 46.9 [9.1] 47.8 [9.1] 47 [8.6] 46. [8.8] 46.5 [8.9] 46.9 [8.]
Physical dependence 92.1% 84.4% 90.6% 91.2% 92.2% 94.6%
Severity of dependence
moderate (3 or 4 items) 33% 41% 34% 32% 33% 32.5%
mild (5 or 6 items) 40% 39,5% 41% 45% 39% 43%
severe (7, 8 or 9 items) 27% 19,5% 25% 23% 28% 24.5%
Duration of alcohol misuse
less than 2 years 5% 6% 5% 5% 8% 6%
3 to 5 years 11% 15% 10% 17.5% 16% 11%
6 to 10 years 8% 19% 10% 17.5% 16% 9.5%
more than 10 years 76% 60%* 75% 60% 60% 73.5%
* p < 0.05Substance Abuse Treatment, Prevention, and Policy 2006, 1:18 http://www.substanceabusepolicy.com/content/1/1/18
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- for both attempts at abstinence and relapses, we
observed no significant differences related to age, gender,
DSM-IV severity, duration of alcohol misuse, occurrence
of a major depressive episode, or prescription of anticrav-
ing drugs or antidepressants.
Trained GPs clearly targeted alcohol dependence. They
knew how to address the alcohol issue and accompany
patients towards drinking cessation. They knew to put
relapses into perspective, considering them as stages in the
process rather than perceiving them as failures. Training
enhanced their ability to motivate patients and to initiate
and repeat attempts at abstinence. It is also likely that the
frequent successive consultations (twofold more consul-
tations scheduled than in the comparison sample) ena-
bled rapid screening of relapses, and thus earlier and
therefore more efficient interventions. On a subjective
level, regular meetings between GPs in the network pro-
vided a forum for discussion of individual cases and
exchange of experience, and probably also enabled the
trained GPs to maintain the necessary resolve to keep
working on high-relapse patients.
Study limitations
The trained sample was formed from a local, experimental
healthcare initiative authorised by the French Ministry of
Health which controlled the adherence to the protocol.
Volunteer practitioners settled the comparative experi-
mentalist design of the study, and thus precluding rand-
omization. The comparison sample comprised the same
number of practitioners, giving a representative sample of
GPs in the same geographical area. Even if physicians were
the primary sampling unit, the evenly-balanced and clini-
cally similar samples of patients provided a good basis for
comparison. The study remained pragmatic, using the reg-
ular practitioner in order to maintain any established
patient-doctor relationships, which overall gives quite
good generalizability.
This intervention combines GP training with application
of a follow-up protocol. Both strategies are easily repro-
ducible despite that self selected GPs had probably
already an interest or a sensitisation about alcohol prob-
lems. The ongoing training through role-playing and the
experience exchange forum (particularly focusing on the
more difficult cases) is more innovative and partly infor-
mal. It is therefore difficult to differentiate the individual
effects of each component in this complex intervention
strategy. Nevertheless, it is probable that the more regular
consultations scheduled by the protocol promoted
patient maturation, and would thus explain the greater
proportion of attempts at abstinence. Similarly, the proto-
col meant that relapses were screened earlier. It is likely
that the alcohol misuse training improved the GPs skills
with alcohol-dependent patients, in particular by ena-
bling them to perceive relapses as stages in the process
rather than failures, and increasing their ability to repeat
attempt at abstinence if necessary.
Kaplan-Meier survival estimates relapses, by sample Figure 3
Kaplan-Meier survival estimates relapses, by sample. The 
abscissa represents follow-up duration in days. Each step is a 
relapse. Data are censored if relapse does not occur. There 
is no difference between the two samples in a Cox regres-
sion test when adjusted.
Relapses
Legend :   ____Comparative sample-Limit Estimate Curve
 _ _ _ Trained sample- Limit Estimate Curve
_____   Censored data
Time
analysis
in days
Survival
distribution
function
Kaplan-Meier survival estimates attempt at abstinence, by  sample Figure 2
Kaplan-Meier survival estimates attempt at abstinence, by 
sample. The abscissa represents follow-up duration in days. 
Each step is an attempt. Data are censored if attempt at 
abstinence does not occur. Difference between the two sam-
ples is significant in a Cox regression test with and without 
adjustment.
Time
analysis
in days Legend :   ____Comparative sample-Limit Estimate Curve
 _ _ _ Trained sample- Limit Estimate Curve
_____   Censored data
Attempt at abstinence
Survival
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Conclusion
This study confirms the crucial role of the GP in the man-
agement of alcohol dependence. Given patients' loyalty to
their practitioners and the very low lost to follow-up rate
in standard general practice, alcohol consumption has to
be a major issue for any GP. Medical training improves the
short-term outcome (few weeks) of alcohol-dependent
patients, i.e. 50% higher attempt at abstinence rates and
twofold longer cumulated abstinence duration than
standard practice.
The quantitative aspect of medical management seems
important. Frequent and regular visits (as planned in the
protocol according to the patients' state of change) give
time for maturation and enforce the patient-practitioner
alliance. Obviously, financial compensation, even if not
an incentive, remains essential for this time-intensive
management strategy.
The maintenance of medium or long-term abstinence
(over few months) does not appear to depend on any kind
of medical management. In both samples, sustained
sobriety appeared to be relatively short and did not exceed
two months. This result highlights the limits of a strictly
medical approach which has to be pre-eminent in the
early stages of abstinence attempt. Maintenance of long-
term abstinence would therefore appear to be far more
dependent on a multidisciplinary management strategy
[21-25]. Prospective orientations for the network include
involving different professionals, collaborating with
social workers and psychologists, and strengthening the
contribution of self-help groups [26,27]. Given the lack of
established guidelines and references, the protocolization
of interventions for all professionals involved (who,
when, how?) remains a challenge.
Methods
This aim of this open, prospective, two-sample study was
to compare management of alcohol-dependent patients
between trained and untrained practitioners. The compar-
ative, quasi-experimental design was devised to compare
an experimental sample of volunteer trained GPs with a
comparison sample [28]. Existing patients were included
over 9 consecutive months by their own practitioner
(whether belonging to the trained network or not) as and
when they became eligible. Patients were therefore not
randomized. Follow-up period was 18 months for each
patient. The protocol was approved by the appropriate
French ethics committees, and all participating patients
signed an informed consent form.
Practitioners and follow-up
The trained sample comprised 24 volunteer practitioners.
Their follow-up fitted protocol D1 (patients with no psy-
chiatric comorbidities other than anxiety or depression,
and management by GP alone), as summarised in figure
1. This protocol is essentially based on a regular consulta-
tion schedule that is lightened as the patient progresses in
a cycle of change through maturation, attempt at absti-
nence, medium-term sustained abstinence (2 months),
and eventually long-term remission. A once-weekly con-
sultation was scheduled during the maturation phase,
then two to three consultations per week over the next
three weeks when attempting at abstinence, and so on.
Further consultations could be scheduled if the GP
deemed it necessary. The idea behind training the GPs was
intended to facilitate and accelerate patient maturation,
both from the outset as well in response to relapses. The
tools used (consumption diary, biological work-ups, etc.)
were designed to act as follow-up indicators or to set
goals, or even to be used as motivational tool. The pre-
scription of medical drugs remained the practitioner's
choice. Only prescriptions of thiamine and benzodi-
azepines (short-term) were made obligatory during with-
drawal, in compliance with the recommendations. It was
systematically recommended that anti-craving drugs were
prescribed.
For the comparison sample, 24 GPs were chosen at ran-
dom from the official public list of physicians to provide
a representative sample (according to age and sex) of GPs
in the same geographical area. GPs forming the compari-
son sample attended sessions in order to become familiar
with the Mini International Neuropsychiatric Interview
(MINI) for diagnosing DSM-IV dependence, anxiety and
mood disorders [29,30]. Consultation frequency in the
comparison sample was open-ended.
Patients
All patients included in the comparison sample were aged
over 18 and met DSM-IV criteria for alcohol dependence.
General exclusion criteria were: patients for whom alco-
hol dependence was not the main diagnosis on axis 1 of
DSM-IV (mental retardation, schizophrenia or other psy-
chotic disorder, bipolar mood disorder), any other addic-
tion (except tobacco), and severe personality disorders (in
particular psychopathic and borderline patients). Subjects
with anxiety or depression were not, however, excluded.
These criteria corresponded to patients attending protocol
stage D1 in the trained sample.
Measures
Patients were described according to the usual sociode-
mographic data. At baseline, severity of dependence was
evaluated by summation of DSM-IV criteria, and simpli-
fied by breakdown into 3 categories: moderate, mild or
severe [31]. DSM-IV criteria were also used to assess phys-
ical dependence. Duration of alcohol misuse was consid-
ered as an indicator of severity.Substance Abuse Treatment, Prevention, and Policy 2006, 1:18 http://www.substanceabusepolicy.com/content/1/1/18
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Given that psychiatric comorbidities can be predictors of
outcome in alcohol dependence [19,32], anxiety and
mood disorders were accurately evaluated at each consul-
tation using the hospital anxiety and depression scale
(HADS) [33] for the trained sample, and the Mini Interna-
tional Neuropsychiatric Interview (MINI) for the compar-
ison sample [29]. Self-questionnaires were avoided in the
comparison sample due to potential bias associated with
maturation.
All medical prescriptions, particularly of benzodi-
azepines, antidepressants and anticraving drugs (acamp-
rosate or naltrexone), were recorded.
Abstinence was the main outcome measure. Patients were
asked to state their alcohol consumption using a detailed
consumption diary or the consumption items in the
AUDIT questionnaire [34]. The highly-specific diary col-
lection in the trained sample can be considered as a moti-
vational tool, and was not used in the comparison sample
as a potential bias. All practitioners had to indicate their
impressions concerning a false declaration of abstinence,
and detail their arguments: patients obviously intoxi-
cated, results of biological work-up, information from the
family circle, etc.
Analysis
Both samples were compared based on sociodemographic
and clinical data.
Patients who died or who were lost to follow-up were
compared between the twosamples, as were percentages
of attempts at abstinence and relapses and averages of
longest period of abstinence and cumulated abstinences.
We conducted a survival analysis based upon Cox regres-
sion as a substitute for logistic regression. This method is
optimal when the dependent variable (attempt at absti-
nence or relapse) is a binary event, and where is also infor-
mation on the length of time to the event (which is the
pattern of the study) or this may be censored if the event
does not occur [35]. Besides, we used more sophisticated
techniques to account for the clustering of patients within
physician and obtained results that were essentially the
same as from simpler analyses assuming independence.
Thus, we present the simpler results only.
Two types of survival curves were plotted using the Kap-
lan-Meier method: curves where each patient could figure
several times (if relapsing then attempting at abstinence
again), thus enabling all data to be drawn together, and
curves (available on request) where each patient could
only appear once, either at first attempt at abstinence or
first relapse, to confirm the results. Curves were compared
using either a log-rank test (for one measurement per
patient) or a Cox model with multiple events per subject
(frailty model [36, 37]) with or without adjustment for
age, gender, severity according to DSM-IV, duration of
alcohol misuse, psychiatric comorbidities, treatments and
consultation frequency (variable corresponding to the
number of consultations divided by duration of follow-
up).
Data analysis and graphic results were performed using
the R statistical package and its "survival" library http://
www.r-project.org. All statistical tests used a two-sided α
risk of 5%. A Mann and Whitney test and Fisher's exact
test were used to compare means and percentages, respec-
tively. Other tests performed (Cox, log-rank) are stated in
the text.
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